Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial

PURPOSE: Dysmenorrhea is a common, recurring, painful condition with a global prevalence of 71%. The treatment regime for dysmenorrhea includes hormonal therapies and NSAID, both of which are associated with side effects. A dose of 10 mg melatonin daily has previously been shown to reduce the level...

Descripción completa

Detalles Bibliográficos
Autores principales: Söderman, Lisa, Edlund, Måns, Böttiger, Ylva, Marions, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748326/
https://www.ncbi.nlm.nih.gov/pubmed/34668986
http://dx.doi.org/10.1007/s00228-021-03234-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748326/
https://www.ncbi.nlm.nih.gov/pubmed/34668986
http://dx.doi.org/10.1007/s00228-021-03234-6

Ejemplares similares